Ritedose Pharmaceuticals Launches <em>Cromolyn Sodium Inhalation Solution, USP (20 mg/2 ml)</em>

COLUMBIA, S.C. (August 24, 2023) – Ritedose, a pharmaceutical manufacturer located in South Carolina, launched a new sterile unit dose generic product, Cromolyn Sodium Inhalation Solution, USP (20 mg/2 ml). The single-dose vial product joins a range of other inhalation solutions produced by Ritedose Pharmaceuticals and is available in cartons

Continue reading